nodes	percent_of_prediction	percent_of_DWPC	metapath
Molindone—HTR2A—phrenic nerve—lung cancer	0.105	0.339	CbGeAlD
Molindone—HTR7—pulmonary artery—lung cancer	0.0614	0.197	CbGeAlD
Molindone—HTR2A—pulmonary artery—lung cancer	0.0383	0.123	CbGeAlD
Molindone—Salivation—Irinotecan—lung cancer	0.014	0.0333	CcSEcCtD
Molindone—Pigmentation disorder—Etoposide—lung cancer	0.0136	0.0322	CcSEcCtD
Molindone—Pigmentation disorder—Paclitaxel—lung cancer	0.0133	0.0315	CcSEcCtD
Molindone—HTR7—respiratory system—lung cancer	0.0103	0.0332	CbGeAlD
Molindone—Akathisia—Irinotecan—lung cancer	0.00982	0.0233	CcSEcCtD
Molindone—DRD2—respiratory system—lung cancer	0.00976	0.0313	CbGeAlD
Molindone—Throat tightness—Etoposide—lung cancer	0.00922	0.0219	CcSEcCtD
Molindone—CHRM1—trachea—lung cancer	0.00896	0.0288	CbGeAlD
Molindone—HTR7—epithelium—lung cancer	0.00863	0.0277	CbGeAlD
Molindone—Dysphagia—Pemetrexed—lung cancer	0.00805	0.0191	CcSEcCtD
Molindone—Weight decreased—Crizotinib—lung cancer	0.00797	0.0189	CcSEcCtD
Molindone—HTR7—trachea—lung cancer	0.00763	0.0245	CbGeAlD
Molindone—Weight decreased—Gefitinib—lung cancer	0.00724	0.0172	CcSEcCtD
Molindone—Pigmentation disorder—Doxorubicin—lung cancer	0.00703	0.0167	CcSEcCtD
Molindone—HTR2A—respiratory system—lung cancer	0.00644	0.0207	CbGeAlD
Molindone—CHRM1—lung—lung cancer	0.00644	0.0207	CbGeAlD
Molindone—ADRA2A—bronchus—lung cancer	0.00623	0.02	CbGeAlD
Molindone—Vision blurred—Crizotinib—lung cancer	0.00579	0.0137	CcSEcCtD
Molindone—ADRA2A—trachea—lung cancer	0.0056	0.018	CbGeAlD
Molindone—Leukopenia—Crizotinib—lung cancer	0.0055	0.013	CcSEcCtD
Molindone—HTR7—lung—lung cancer	0.00548	0.0176	CbGeAlD
Molindone—HTR2A—epithelium—lung cancer	0.00538	0.0173	CbGeAlD
Molindone—Salivary hypersecretion—Irinotecan—lung cancer	0.00528	0.0125	CcSEcCtD
Molindone—ADRA2A—cardiac atrium—lung cancer	0.00526	0.0169	CbGeAlD
Molindone—DRD2—lung—lung cancer	0.00518	0.0166	CbGeAlD
Molindone—Leukopenia—Pemetrexed—lung cancer	0.00502	0.0119	CcSEcCtD
Molindone—Dysphagia—Erlotinib—lung cancer	0.00478	0.0114	CcSEcCtD
Molindone—HTR2A—trachea—lung cancer	0.00476	0.0153	CbGeAlD
Molindone—Dyskinesia—Paclitaxel—lung cancer	0.00472	0.0112	CcSEcCtD
Molindone—Dry mouth—Gefitinib—lung cancer	0.00464	0.011	CcSEcCtD
Molindone—Dyspnoea—Crizotinib—lung cancer	0.00447	0.0106	CcSEcCtD
Molindone—Weight increased—Topotecan—lung cancer	0.0044	0.0104	CcSEcCtD
Molindone—Weight decreased—Erlotinib—lung cancer	0.00433	0.0103	CcSEcCtD
Molindone—Constipation—Crizotinib—lung cancer	0.00429	0.0102	CcSEcCtD
Molindone—Amenorrhoea—Docetaxel—lung cancer	0.00428	0.0102	CcSEcCtD
Molindone—Hypotension—Gefitinib—lung cancer	0.00425	0.0101	CcSEcCtD
Molindone—Agitation—Teniposide—lung cancer	0.00418	0.00991	CcSEcCtD
Molindone—Dysphagia—Vinorelbine—lung cancer	0.00414	0.00982	CcSEcCtD
Molindone—Dyspnoea—Pemetrexed—lung cancer	0.00408	0.00969	CcSEcCtD
Molindone—Leukopenia—Teniposide—lung cancer	0.00407	0.00966	CcSEcCtD
Molindone—Dyspnoea—Gefitinib—lung cancer	0.00406	0.00963	CcSEcCtD
Molindone—ADRA2A—lung—lung cancer	0.00402	0.0129	CbGeAlD
Molindone—Constipation—Pemetrexed—lung cancer	0.00392	0.0093	CcSEcCtD
Molindone—Constipation—Gefitinib—lung cancer	0.00389	0.00924	CcSEcCtD
Molindone—Weight decreased—Vinorelbine—lung cancer	0.00374	0.00888	CcSEcCtD
Molindone—Tachycardia—Teniposide—lung cancer	0.00362	0.00859	CcSEcCtD
Molindone—Hypotension—Teniposide—lung cancer	0.00347	0.00823	CcSEcCtD
Molindone—HTR2A—lung—lung cancer	0.00342	0.011	CbGeAlD
Molindone—Dyspnoea—Teniposide—lung cancer	0.00331	0.00785	CcSEcCtD
Molindone—Muscle spasms—Topotecan—lung cancer	0.00324	0.00769	CcSEcCtD
Molindone—Rash—Crizotinib—lung cancer	0.00316	0.0075	CcSEcCtD
Molindone—Dermatitis—Crizotinib—lung cancer	0.00316	0.00749	CcSEcCtD
Molindone—Leukopenia—Vinblastine—lung cancer	0.0031	0.00737	CcSEcCtD
Molindone—Weight decreased—Irinotecan—lung cancer	0.00309	0.00733	CcSEcCtD
Molindone—Leukopenia—Topotecan—lung cancer	0.00302	0.00716	CcSEcCtD
Molindone—Nausea—Crizotinib—lung cancer	0.00298	0.00707	CcSEcCtD
Molindone—Rash—Pemetrexed—lung cancer	0.00289	0.00685	CcSEcCtD
Molindone—Dermatitis—Pemetrexed—lung cancer	0.00289	0.00685	CcSEcCtD
Molindone—Rash—Gefitinib—lung cancer	0.00287	0.00681	CcSEcCtD
Molindone—Dermatitis—Gefitinib—lung cancer	0.00287	0.0068	CcSEcCtD
Molindone—Dysphagia—Etoposide—lung cancer	0.00284	0.00673	CcSEcCtD
Molindone—Dysphagia—Paclitaxel—lung cancer	0.00278	0.0066	CcSEcCtD
Molindone—ADRA2A—lymph node—lung cancer	0.00275	0.00883	CbGeAlD
Molindone—Nausea—Pemetrexed—lung cancer	0.00272	0.00646	CcSEcCtD
Molindone—Nausea—Gefitinib—lung cancer	0.0027	0.00642	CcSEcCtD
Molindone—Amenorrhoea—Doxorubicin—lung cancer	0.00267	0.00634	CcSEcCtD
Molindone—Leukopenia—Vinorelbine—lung cancer	0.00258	0.00612	CcSEcCtD
Molindone—Weight increased—Paclitaxel—lung cancer	0.00253	0.00601	CcSEcCtD
Molindone—Weight decreased—Paclitaxel—lung cancer	0.00252	0.00597	CcSEcCtD
Molindone—Dyskinesia—Doxorubicin—lung cancer	0.0025	0.00592	CcSEcCtD
Molindone—Dyspnoea—Topotecan—lung cancer	0.00245	0.00582	CcSEcCtD
Molindone—Dyspnoea—Erlotinib—lung cancer	0.00243	0.00576	CcSEcCtD
Molindone—Gynaecomastia—Methotrexate—lung cancer	0.00242	0.00575	CcSEcCtD
Molindone—Constipation—Vinblastine—lung cancer	0.00242	0.00574	CcSEcCtD
Molindone—Dysphagia—Docetaxel—lung cancer	0.00236	0.0056	CcSEcCtD
Molindone—Constipation—Topotecan—lung cancer	0.00235	0.00558	CcSEcCtD
Molindone—Rash—Teniposide—lung cancer	0.00234	0.00555	CcSEcCtD
Molindone—Dermatitis—Teniposide—lung cancer	0.00234	0.00555	CcSEcCtD
Molindone—Constipation—Erlotinib—lung cancer	0.00233	0.00552	CcSEcCtD
Molindone—Tachycardia—Vinorelbine—lung cancer	0.0023	0.00545	CcSEcCtD
Molindone—Muscle spasms—Irinotecan—lung cancer	0.00229	0.00542	CcSEcCtD
Molindone—Salivary hypersecretion—Doxorubicin—lung cancer	0.00228	0.00541	CcSEcCtD
Molindone—Nausea—Teniposide—lung cancer	0.0022	0.00523	CcSEcCtD
Molindone—Hypotension—Vinorelbine—lung cancer	0.0022	0.00522	CcSEcCtD
Molindone—Weight increased—Docetaxel—lung cancer	0.00215	0.00509	CcSEcCtD
Molindone—Weight decreased—Docetaxel—lung cancer	0.00213	0.00506	CcSEcCtD
Molindone—Leukopenia—Irinotecan—lung cancer	0.00213	0.00505	CcSEcCtD
Molindone—Dyspnoea—Vinorelbine—lung cancer	0.0021	0.00498	CcSEcCtD
Molindone—Muscle spasms—Cisplatin—lung cancer	0.00208	0.00492	CcSEcCtD
Molindone—Leukopenia—Gemcitabine—lung cancer	0.00207	0.00492	CcSEcCtD
Molindone—Vision blurred—Cisplatin—lung cancer	0.00203	0.00483	CcSEcCtD
Molindone—Tremor—Cisplatin—lung cancer	0.00202	0.0048	CcSEcCtD
Molindone—Constipation—Vinorelbine—lung cancer	0.00201	0.00477	CcSEcCtD
Molindone—Leukopenia—Cisplatin—lung cancer	0.00193	0.00458	CcSEcCtD
Molindone—Muscle spasms—Etoposide—lung cancer	0.0019	0.00451	CcSEcCtD
Molindone—Muscle spasms—Paclitaxel—lung cancer	0.00186	0.00442	CcSEcCtD
Molindone—Vision blurred—Paclitaxel—lung cancer	0.00183	0.00434	CcSEcCtD
Molindone—Tremor—Paclitaxel—lung cancer	0.00182	0.00431	CcSEcCtD
Molindone—Hypotension—Irinotecan—lung cancer	0.00181	0.0043	CcSEcCtD
Molindone—Agitation—Paclitaxel—lung cancer	0.00178	0.00423	CcSEcCtD
Molindone—Leukopenia—Etoposide—lung cancer	0.00177	0.0042	CcSEcCtD
Molindone—Hypotension—Gemcitabine—lung cancer	0.00177	0.00419	CcSEcCtD
Molindone—Leukopenia—Paclitaxel—lung cancer	0.00174	0.00412	CcSEcCtD
Molindone—Rash—Topotecan—lung cancer	0.00173	0.00411	CcSEcCtD
Molindone—Dermatitis—Topotecan—lung cancer	0.00173	0.00411	CcSEcCtD
Molindone—Dyspnoea—Irinotecan—lung cancer	0.00173	0.0041	CcSEcCtD
Molindone—Somnolence—Irinotecan—lung cancer	0.00172	0.00409	CcSEcCtD
Molindone—Tachycardia—Cisplatin—lung cancer	0.00172	0.00408	CcSEcCtD
Molindone—Rash—Erlotinib—lung cancer	0.00172	0.00407	CcSEcCtD
Molindone—Dermatitis—Erlotinib—lung cancer	0.00171	0.00407	CcSEcCtD
Molindone—Dyspnoea—Gemcitabine—lung cancer	0.00168	0.004	CcSEcCtD
Molindone—Nausea—Vinblastine—lung cancer	0.00168	0.00399	CcSEcCtD
Molindone—Somnolence—Gemcitabine—lung cancer	0.00168	0.00399	CcSEcCtD
Molindone—Constipation—Irinotecan—lung cancer	0.00166	0.00394	CcSEcCtD
Molindone—Hypotension—Cisplatin—lung cancer	0.00165	0.00391	CcSEcCtD
Molindone—Nausea—Topotecan—lung cancer	0.00163	0.00388	CcSEcCtD
Molindone—Constipation—Gemcitabine—lung cancer	0.00162	0.00384	CcSEcCtD
Molindone—Nausea—Erlotinib—lung cancer	0.00162	0.00384	CcSEcCtD
Molindone—Dry mouth—Paclitaxel—lung cancer	0.00161	0.00383	CcSEcCtD
Molindone—Muscle spasms—Docetaxel—lung cancer	0.00158	0.00375	CcSEcCtD
Molindone—Tachycardia—Etoposide—lung cancer	0.00158	0.00374	CcSEcCtD
Molindone—Dyspnoea—Cisplatin—lung cancer	0.00157	0.00373	CcSEcCtD
Molindone—Tachycardia—Paclitaxel—lung cancer	0.00154	0.00366	CcSEcCtD
Molindone—Drowsiness—Methotrexate—lung cancer	0.00152	0.0036	CcSEcCtD
Molindone—Hypotension—Etoposide—lung cancer	0.00151	0.00358	CcSEcCtD
Molindone—Rash—Vinorelbine—lung cancer	0.00148	0.00352	CcSEcCtD
Molindone—Dermatitis—Vinorelbine—lung cancer	0.00148	0.00352	CcSEcCtD
Molindone—Hypotension—Paclitaxel—lung cancer	0.00148	0.00351	CcSEcCtD
Molindone—Dysphagia—Doxorubicin—lung cancer	0.00147	0.00349	CcSEcCtD
Molindone—Leukopenia—Docetaxel—lung cancer	0.00147	0.00349	CcSEcCtD
Molindone—Dyspnoea—Etoposide—lung cancer	0.00144	0.00341	CcSEcCtD
Molindone—Somnolence—Etoposide—lung cancer	0.00143	0.0034	CcSEcCtD
Molindone—Dyspnoea—Paclitaxel—lung cancer	0.00141	0.00335	CcSEcCtD
Molindone—Somnolence—Paclitaxel—lung cancer	0.00141	0.00334	CcSEcCtD
Molindone—Nausea—Vinorelbine—lung cancer	0.0014	0.00332	CcSEcCtD
Molindone—Constipation—Etoposide—lung cancer	0.00138	0.00328	CcSEcCtD
Molindone—Dry mouth—Docetaxel—lung cancer	0.00137	0.00325	CcSEcCtD
Molindone—Constipation—Paclitaxel—lung cancer	0.00135	0.00321	CcSEcCtD
Molindone—Weight increased—Doxorubicin—lung cancer	0.00134	0.00318	CcSEcCtD
Molindone—Weight decreased—Doxorubicin—lung cancer	0.00133	0.00316	CcSEcCtD
Molindone—Drowsiness—Doxorubicin—lung cancer	0.00131	0.00311	CcSEcCtD
Molindone—Tachycardia—Docetaxel—lung cancer	0.00131	0.00311	CcSEcCtD
Molindone—Hypotension—Docetaxel—lung cancer	0.00125	0.00297	CcSEcCtD
Molindone—Rash—Irinotecan—lung cancer	0.00122	0.0029	CcSEcCtD
Molindone—Dermatitis—Irinotecan—lung cancer	0.00122	0.0029	CcSEcCtD
Molindone—Dyspnoea—Docetaxel—lung cancer	0.0012	0.00284	CcSEcCtD
Molindone—Somnolence—Docetaxel—lung cancer	0.00119	0.00283	CcSEcCtD
Molindone—Rash—Gemcitabine—lung cancer	0.00119	0.00283	CcSEcCtD
Molindone—Dermatitis—Gemcitabine—lung cancer	0.00119	0.00283	CcSEcCtD
Molindone—Nausea—Irinotecan—lung cancer	0.00115	0.00273	CcSEcCtD
Molindone—Constipation—Docetaxel—lung cancer	0.00115	0.00272	CcSEcCtD
Molindone—Nausea—Gemcitabine—lung cancer	0.00112	0.00266	CcSEcCtD
Molindone—Vision blurred—Methotrexate—lung cancer	0.00112	0.00265	CcSEcCtD
Molindone—Rash—Cisplatin—lung cancer	0.00111	0.00264	CcSEcCtD
Molindone—Dermatitis—Cisplatin—lung cancer	0.00111	0.00263	CcSEcCtD
Molindone—Leukopenia—Methotrexate—lung cancer	0.00106	0.00252	CcSEcCtD
Molindone—Nausea—Cisplatin—lung cancer	0.00105	0.00248	CcSEcCtD
Molindone—Rash—Etoposide—lung cancer	0.00102	0.00241	CcSEcCtD
Molindone—Dermatitis—Etoposide—lung cancer	0.00102	0.00241	CcSEcCtD
Molindone—Rash—Paclitaxel—lung cancer	0.000998	0.00237	CcSEcCtD
Molindone—Dermatitis—Paclitaxel—lung cancer	0.000997	0.00237	CcSEcCtD
Molindone—Muscle spasms—Doxorubicin—lung cancer	0.000986	0.00234	CcSEcCtD
Molindone—Vision blurred—Doxorubicin—lung cancer	0.000967	0.00229	CcSEcCtD
Molindone—Nausea—Etoposide—lung cancer	0.000959	0.00227	CcSEcCtD
Molindone—Agitation—Doxorubicin—lung cancer	0.000942	0.00224	CcSEcCtD
Molindone—Nausea—Paclitaxel—lung cancer	0.00094	0.00223	CcSEcCtD
Molindone—Leukopenia—Doxorubicin—lung cancer	0.000918	0.00218	CcSEcCtD
Molindone—Hypotension—Methotrexate—lung cancer	0.000903	0.00214	CcSEcCtD
Molindone—Dyspnoea—Methotrexate—lung cancer	0.000862	0.00205	CcSEcCtD
Molindone—Somnolence—Methotrexate—lung cancer	0.000859	0.00204	CcSEcCtD
Molindone—Dry mouth—Doxorubicin—lung cancer	0.000854	0.00203	CcSEcCtD
Molindone—Rash—Docetaxel—lung cancer	0.000846	0.00201	CcSEcCtD
Molindone—Dermatitis—Docetaxel—lung cancer	0.000845	0.002	CcSEcCtD
Molindone—Tachycardia—Doxorubicin—lung cancer	0.000817	0.00194	CcSEcCtD
Molindone—Nausea—Docetaxel—lung cancer	0.000797	0.00189	CcSEcCtD
Molindone—Hypotension—Doxorubicin—lung cancer	0.000782	0.00186	CcSEcCtD
Molindone—Dyspnoea—Doxorubicin—lung cancer	0.000746	0.00177	CcSEcCtD
Molindone—Somnolence—Doxorubicin—lung cancer	0.000744	0.00177	CcSEcCtD
Molindone—Constipation—Doxorubicin—lung cancer	0.000716	0.0017	CcSEcCtD
Molindone—Rash—Methotrexate—lung cancer	0.000609	0.00145	CcSEcCtD
Molindone—Dermatitis—Methotrexate—lung cancer	0.000609	0.00145	CcSEcCtD
Molindone—Nausea—Methotrexate—lung cancer	0.000574	0.00136	CcSEcCtD
Molindone—Rash—Doxorubicin—lung cancer	0.000528	0.00125	CcSEcCtD
Molindone—Dermatitis—Doxorubicin—lung cancer	0.000527	0.00125	CcSEcCtD
Molindone—Nausea—Doxorubicin—lung cancer	0.000497	0.00118	CcSEcCtD
Molindone—ADRA2A—Hemostasis—AKT1—lung cancer	4.7e-05	0.000176	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PIK3CD—lung cancer	4.67e-05	0.000175	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—KIT—lung cancer	4.66e-05	0.000175	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CG—lung cancer	4.66e-05	0.000175	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—APC—lung cancer	4.66e-05	0.000175	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—NRAS—lung cancer	4.66e-05	0.000175	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—AKT1—lung cancer	4.63e-05	0.000173	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—CREBBP—lung cancer	4.63e-05	0.000173	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—PIK3CA—lung cancer	4.62e-05	0.000173	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—EGF—lung cancer	4.61e-05	0.000172	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—APC—lung cancer	4.59e-05	0.000172	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CG—lung cancer	4.59e-05	0.000172	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—KIT—lung cancer	4.59e-05	0.000172	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—NRAS—lung cancer	4.59e-05	0.000172	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—APOA1—lung cancer	4.57e-05	0.000171	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—KRAS—lung cancer	4.57e-05	0.000171	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—APC—lung cancer	4.56e-05	0.000171	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—KIT—lung cancer	4.56e-05	0.000171	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CG—lung cancer	4.56e-05	0.000171	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—NRAS—lung cancer	4.56e-05	0.000171	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—EGF—lung cancer	4.54e-05	0.00017	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—KDR—lung cancer	4.53e-05	0.00017	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—EP300—lung cancer	4.53e-05	0.000169	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—EGF—lung cancer	4.51e-05	0.000169	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—MAPK3—lung cancer	4.47e-05	0.000167	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—POMC—lung cancer	4.44e-05	0.000166	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—SRC—lung cancer	4.4e-05	0.000165	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—MAPK3—lung cancer	4.39e-05	0.000164	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3CD—lung cancer	4.39e-05	0.000164	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—BRAF—lung cancer	4.38e-05	0.000164	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—MAPK3—lung cancer	4.37e-05	0.000164	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—POMC—lung cancer	4.37e-05	0.000163	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—POMC—lung cancer	4.34e-05	0.000163	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—ALB—lung cancer	4.33e-05	0.000162	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL6R—lung cancer	4.33e-05	0.000162	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CREBBP—lung cancer	4.32e-05	0.000162	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—BRAF—lung cancer	4.31e-05	0.000161	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—BRAF—lung cancer	4.29e-05	0.000161	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—VEGFA—lung cancer	4.29e-05	0.00016	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL6R—lung cancer	4.26e-05	0.000159	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CREBBP—lung cancer	4.25e-05	0.000159	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—EGFR—lung cancer	4.25e-05	0.000159	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—STAT3—lung cancer	4.24e-05	0.000159	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL6R—lung cancer	4.24e-05	0.000159	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—NRAS—lung cancer	4.23e-05	0.000158	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CREBBP—lung cancer	4.23e-05	0.000158	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—PIK3CA—lung cancer	4.2e-05	0.000157	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MDM2—lung cancer	4.18e-05	0.000157	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—EGFR—lung cancer	4.18e-05	0.000156	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—APC—lung cancer	4.17e-05	0.000156	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CG—lung cancer	4.17e-05	0.000156	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—KIT—lung cancer	4.17e-05	0.000156	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—NRAS—lung cancer	4.17e-05	0.000156	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—RAF1—lung cancer	4.17e-05	0.000156	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—EGFR—lung cancer	4.16e-05	0.000156	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MAP2K1—lung cancer	4.13e-05	0.000154	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—EGF—lung cancer	4.13e-05	0.000154	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—ERBB2—lung cancer	4.12e-05	0.000154	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CD—lung cancer	4.1e-05	0.000153	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MTOR—lung cancer	4.07e-05	0.000152	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PIK3CB—lung cancer	4.07e-05	0.000152	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—PIK3CA—lung cancer	4.06e-05	0.000152	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MAP2K1—lung cancer	4.06e-05	0.000152	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MAPK3—lung cancer	4.06e-05	0.000152	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MAP2K1—lung cancer	4.04e-05	0.000151	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CD—lung cancer	4.03e-05	0.000151	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—KRAS—lung cancer	4.01e-05	0.00015	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CD—lung cancer	4.01e-05	0.00015	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—MAPK3—lung cancer	4e-05	0.00015	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—PIK3CA—lung cancer	4e-05	0.00015	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—PIK3CA—lung cancer	3.97e-05	0.000149	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—POMC—lung cancer	3.97e-05	0.000149	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—KRAS—lung cancer	3.95e-05	0.000148	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MYC—lung cancer	3.94e-05	0.000148	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—KRAS—lung cancer	3.93e-05	0.000147	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—BRAF—lung cancer	3.92e-05	0.000147	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CXCL8—lung cancer	3.91e-05	0.000146	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—HRAS—lung cancer	3.89e-05	0.000145	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IL6R—lung cancer	3.88e-05	0.000145	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CREBBP—lung cancer	3.87e-05	0.000145	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—EGFR—lung cancer	3.86e-05	0.000144	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3CB—lung cancer	3.83e-05	0.000143	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—EGFR—lung cancer	3.8e-05	0.000142	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PTGS2—lung cancer	3.79e-05	0.000142	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—AKT1—lung cancer	3.78e-05	0.000141	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CASP3—lung cancer	3.74e-05	0.00014	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IL2—lung cancer	3.74e-05	0.00014	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—IL6—lung cancer	3.72e-05	0.000139	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MAP2K1—lung cancer	3.69e-05	0.000138	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—PIK3CA—lung cancer	3.69e-05	0.000138	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MDM2—lung cancer	3.67e-05	0.000137	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CD—lung cancer	3.67e-05	0.000137	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—RAF1—lung cancer	3.66e-05	0.000137	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—KRAS—lung cancer	3.64e-05	0.000136	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CCND1—lung cancer	3.64e-05	0.000136	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—JUN—lung cancer	3.64e-05	0.000136	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—PIK3CA—lung cancer	3.64e-05	0.000136	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—PIK3CA—lung cancer	3.63e-05	0.000136	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—ERBB2—lung cancer	3.62e-05	0.000136	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MDM2—lung cancer	3.61e-05	0.000135	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—PIK3CA—lung cancer	3.61e-05	0.000135	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—RAF1—lung cancer	3.6e-05	0.000135	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MDM2—lung cancer	3.59e-05	0.000135	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—KRAS—lung cancer	3.59e-05	0.000134	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—RAF1—lung cancer	3.58e-05	0.000134	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CB—lung cancer	3.57e-05	0.000134	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MTOR—lung cancer	3.57e-05	0.000134	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—ERBB2—lung cancer	3.56e-05	0.000133	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—ERBB2—lung cancer	3.54e-05	0.000133	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MMP9—lung cancer	3.54e-05	0.000132	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CDKN1A—lung cancer	3.52e-05	0.000132	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PTEN—lung cancer	3.52e-05	0.000132	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MTOR—lung cancer	3.52e-05	0.000132	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CB—lung cancer	3.52e-05	0.000132	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MTOR—lung cancer	3.5e-05	0.000131	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CB—lung cancer	3.5e-05	0.000131	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CXCL8—lung cancer	3.43e-05	0.000128	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—AKT1—lung cancer	3.43e-05	0.000128	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—HRAS—lung cancer	3.41e-05	0.000128	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CXCL8—lung cancer	3.38e-05	0.000126	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CXCL8—lung cancer	3.36e-05	0.000126	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—HRAS—lung cancer	3.36e-05	0.000126	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—EP300—lung cancer	3.35e-05	0.000126	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—PIK3CA—lung cancer	3.35e-05	0.000125	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—HRAS—lung cancer	3.34e-05	0.000125	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—AKT1—lung cancer	3.32e-05	0.000124	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PTEN—lung cancer	3.31e-05	0.000124	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—PIK3CA—lung cancer	3.3e-05	0.000124	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MDM2—lung cancer	3.29e-05	0.000123	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CASP3—lung cancer	3.29e-05	0.000123	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL2—lung cancer	3.28e-05	0.000123	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—RAF1—lung cancer	3.28e-05	0.000123	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—IL6—lung cancer	3.27e-05	0.000122	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—AKT1—lung cancer	3.26e-05	0.000122	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—SRC—lung cancer	3.26e-05	0.000122	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—AKT1—lung cancer	3.25e-05	0.000121	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—ERBB2—lung cancer	3.24e-05	0.000121	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—TP53—lung cancer	3.24e-05	0.000121	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CASP3—lung cancer	3.23e-05	0.000121	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL2—lung cancer	3.23e-05	0.000121	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CASP3—lung cancer	3.22e-05	0.00012	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—IL6—lung cancer	3.21e-05	0.00012	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL2—lung cancer	3.21e-05	0.00012	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CCND1—lung cancer	3.2e-05	0.00012	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MTOR—lung cancer	3.2e-05	0.00012	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CB—lung cancer	3.2e-05	0.00012	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—IL6—lung cancer	3.2e-05	0.00012	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—JUN—lung cancer	3.19e-05	0.000119	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—VEGFA—lung cancer	3.18e-05	0.000119	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—EP300—lung cancer	3.15e-05	0.000118	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CCND1—lung cancer	3.15e-05	0.000118	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—STAT3—lung cancer	3.15e-05	0.000118	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—JUN—lung cancer	3.14e-05	0.000118	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—NRAS—lung cancer	3.14e-05	0.000117	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CCND1—lung cancer	3.13e-05	0.000117	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—JUN—lung cancer	3.12e-05	0.000117	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MMP9—lung cancer	3.11e-05	0.000116	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—HRAS—lung cancer	3.1e-05	0.000116	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CDKN1A—lung cancer	3.09e-05	0.000116	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PTEN—lung cancer	3.09e-05	0.000116	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CXCL8—lung cancer	3.07e-05	0.000115	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MMP9—lung cancer	3.06e-05	0.000114	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—HRAS—lung cancer	3.05e-05	0.000114	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CDKN1A—lung cancer	3.05e-05	0.000114	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MMP9—lung cancer	3.04e-05	0.000114	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PTEN—lung cancer	3.04e-05	0.000114	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CDKN1A—lung cancer	3.03e-05	0.000113	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PTEN—lung cancer	3.02e-05	0.000113	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—AKT1—lung cancer	3.01e-05	0.000113	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MAPK3—lung cancer	3e-05	0.000112	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	2.97e-05	0.000111	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—IL6—lung cancer	2.96e-05	0.000111	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—AKT1—lung cancer	2.96e-05	0.000111	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—AKT1—lung cancer	2.95e-05	0.00011	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—EP300—lung cancer	2.94e-05	0.00011	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CASP3—lung cancer	2.94e-05	0.00011	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IL2—lung cancer	2.94e-05	0.00011	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—IL6—lung cancer	2.92e-05	0.000109	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MYC—lung cancer	2.92e-05	0.000109	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—EP300—lung cancer	2.9e-05	0.000108	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—EP300—lung cancer	2.88e-05	0.000108	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCND1—lung cancer	2.86e-05	0.000107	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—SRC—lung cancer	2.86e-05	0.000107	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—EGFR—lung cancer	2.86e-05	0.000107	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—JUN—lung cancer	2.86e-05	0.000107	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—SRC—lung cancer	2.82e-05	0.000105	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—SRC—lung cancer	2.8e-05	0.000105	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—VEGFA—lung cancer	2.79e-05	0.000104	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MMP9—lung cancer	2.78e-05	0.000104	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	2.77e-05	0.000104	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PTEN—lung cancer	2.76e-05	0.000103	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—STAT3—lung cancer	2.76e-05	0.000103	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—NRAS—lung cancer	2.75e-05	0.000103	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—VEGFA—lung cancer	2.74e-05	0.000103	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—AKT1—lung cancer	2.74e-05	0.000102	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—VEGFA—lung cancer	2.73e-05	0.000102	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—STAT3—lung cancer	2.72e-05	0.000102	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—NRAS—lung cancer	2.71e-05	0.000101	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—STAT3—lung cancer	2.7e-05	0.000101	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—KRAS—lung cancer	2.7e-05	0.000101	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—AKT1—lung cancer	2.7e-05	0.000101	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—NRAS—lung cancer	2.7e-05	0.000101	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MAPK3—lung cancer	2.64e-05	9.87e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—EP300—lung cancer	2.64e-05	9.86e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MAPK3—lung cancer	2.6e-05	9.71e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MAPK3—lung cancer	2.58e-05	9.66e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MYC—lung cancer	2.57e-05	9.6e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—SRC—lung cancer	2.56e-05	9.59e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MYC—lung cancer	2.52e-05	9.45e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MYC—lung cancer	2.51e-05	9.4e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—EGFR—lung cancer	2.51e-05	9.39e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—VEGFA—lung cancer	2.5e-05	9.34e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PIK3CA—lung cancer	2.48e-05	9.28e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—STAT3—lung cancer	2.47e-05	9.25e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—EGFR—lung cancer	2.47e-05	9.24e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NRAS—lung cancer	2.47e-05	9.23e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—EGFR—lung cancer	2.46e-05	9.19e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—TP53—lung cancer	2.4e-05	8.98e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—KRAS—lung cancer	2.37e-05	8.87e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MAPK3—lung cancer	2.36e-05	8.84e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—KRAS—lung cancer	2.33e-05	8.73e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3CA—lung cancer	2.33e-05	8.73e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—KRAS—lung cancer	2.32e-05	8.68e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MYC—lung cancer	2.3e-05	8.6e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—HRAS—lung cancer	2.3e-05	8.59e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—EGFR—lung cancer	2.25e-05	8.41e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IL6—lung cancer	2.2e-05	8.22e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CA—lung cancer	2.18e-05	8.15e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CA—lung cancer	2.14e-05	8.02e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CA—lung cancer	2.13e-05	7.98e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—KRAS—lung cancer	2.12e-05	7.94e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—TP53—lung cancer	2.11e-05	7.89e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—TP53—lung cancer	2.07e-05	7.76e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—TP53—lung cancer	2.06e-05	7.72e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—AKT1—lung cancer	2.03e-05	7.58e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—HRAS—lung cancer	2.02e-05	7.54e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—HRAS—lung cancer	1.98e-05	7.42e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—HRAS—lung cancer	1.97e-05	7.38e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	1.95e-05	7.3e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL6—lung cancer	1.93e-05	7.22e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—AKT1—lung cancer	1.91e-05	7.13e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL6—lung cancer	1.9e-05	7.1e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL6—lung cancer	1.89e-05	7.06e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—TP53—lung cancer	1.89e-05	7.06e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—HRAS—lung cancer	1.8e-05	6.75e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—AKT1—lung cancer	1.78e-05	6.66e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—AKT1—lung cancer	1.75e-05	6.55e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—AKT1—lung cancer	1.74e-05	6.52e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IL6—lung cancer	1.73e-05	6.46e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—AKT1—lung cancer	1.59e-05	5.96e-05	CbGpPWpGaD
